SymbolBRKRP
NameBRUKER CORP
SectorINDUSTRIALS
RegionNorth America
IndustryLaboratory Analytical Instruments
Address40 MANNING RD, BILLERICA, MA 01821
Telephone978663-3660
Fax
Email
Websitehttps://www.bruker.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001109354
Description

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Brukers revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world.

Additional info from NASDAQ:
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Brukers revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world.

2026-07-24 20:01

Bruker - Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

Read more
2026-07-24 20:01

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

Read more
2026-07-16 20:15

Munch Mark 🟡 adjusted position in 2.0K shares (1 derivative) of BRUKER CORP (BRKR) at $60.25 Transaction Date: Jul 15, 2026 | Filing ID: 000018

Read more
2026-07-15 20:12

📋 MARK R MUNCH (Officer) plans to sell 2K shares of Bruker Corporation (at $60.25 each, total $120K) Filed: Jul 15, 2026 | ID: 007092

Read more
2026-07-15 11:00

Bruker - Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

Read more
2026-06-16 20:15

Munch Mark 🟡 adjusted position in 2.0K shares (1 derivative) of BRUKER CORP (BRKR) at $54.76 Transaction Date: Jun 15, 2026 | Filing ID: 000016

Read more
2026-06-15 20:38

📋 MARK R MUNCH (Officer) plans to sell 2K shares of Bruker Corporation (at $54.76 each, total $110K) Filed: Jun 15, 2026 | ID: 006100

Read more
2026-06-12 17:16

New Form S-3ASR - BRUKER CORP <b>Filed:</b> 2026-06-12 <b>AccNo:</b> 0001193125-26-269460 <b>Size:</b> 1 MB

Read more
2026-06-04 11:00

Bruker - Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Read more
2026-06-04 11:00

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Read more